The Pharma Direct-to-Consumer Shift: Moving Faster Than Infrastructure Can Handle
From PharmaSource Podcast by Life Science Networks
April 6, 2026 · 27 min
About this episode
Ryan Kelly discusses the rapid transformation of the pharmaceutical industry towards direct-to-consumer models and the challenges it poses to existing infrastructure.
“We’re witnessing what I would consider the most structurally disruptive pharmaceutical moment I’ve seen in my career—and it’s being driven by consumers.” Ryan Kelly , Interim CEO and Senior Director of Supply Chain Security and Brand Protection at Rx-360, has seen pharma’s direct-to-consumer transformation from multiple angles—building pharmacy operations at Amazon during the PillPack acquisition, scaling the largest cash pharmacy in the U.S. at Chewy, and now leading supply chain security for a 130-member industry consortium. His verdict: the infrastructure isn’t keeping up. In the latest PharmaSource podcast episode , Ryan explains why GLP-1 demand and the rise of direct-to-consumer platforms such as TrumpRX have become the stress test pharma’s supply chain never prepared for—and what manufacturers need to do before the system breaks.
People in this episode
Guest: Ryan Kelly
Topics covered
- pharmaceutical industry
- direct-to-consumer
- supply chain
- consumer demand
- infrastructure challenges
Keywords
- pharmaceutical
- direct-to-consumer
- supply chain
- GLP-1
- consumer demand
Mentioned in this episode
Organizations: Rx-360, Amazon, PillPack, Chewy, TrumpRX
More episodes of PharmaSource Podcast
- How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar · June 11, 2026 · 31 min
- The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma's Global Strategy · June 8, 2026 · 18 min
- How to Build a Resilient Global Vaccine Supply Chain: From Crisis to Capability · June 4, 2026 · 46 min
- How Lonza Is Outgrowing the CDMO Market with Bioconjugation, AI, and Regionalization · May 31, 2026 · 29 min
- The Strategic Partnership Gap: Why CDMOs Are Meeting Pharma's Expectations Less Than Half the Time with Simon-Kucher · May 27, 2026 · 26 min
- Creative Financing Strategies for Biotech's Bear Market, Beyond the VC Round · May 25, 2026 · 29 min
Explore listener stats, chart rankings, contacts and more on the PharmaSource Podcast podcast page.